pubmed-article:16460862 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16460862 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
pubmed-article:16460862 | lifeskim:mentions | umls-concept:C0085474 | lld:lifeskim |
pubmed-article:16460862 | lifeskim:mentions | umls-concept:C0021920 | lld:lifeskim |
pubmed-article:16460862 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
pubmed-article:16460862 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
pubmed-article:16460862 | lifeskim:mentions | umls-concept:C1523987 | lld:lifeskim |
pubmed-article:16460862 | lifeskim:mentions | umls-concept:C1519193 | lld:lifeskim |
pubmed-article:16460862 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:16460862 | pubmed:dateCreated | 2006-7-21 | lld:pubmed |
pubmed-article:16460862 | pubmed:abstractText | RmInt1 is a mobile group II intron which interrupts ISRm2011-2, another mobile element from the bacterium Sinorhizobium meliloti. Ribozyme constructs derived from intron RmInt1 self-splice in vitro when incubated under permissive conditions, but the excised intron and ligated exons are largely replaced by unconventional products. These include a slightly shorter, 5'-end truncated 3' exon, truncated variants of the linear and lariat forms of the intron-3' exon reaction intermediate, as well as presumably circular molecules derived from the latter. Two factors explain the abundance of these products: (i) nucleotides 5-11 of the 3' exon (IBS1*) provide a better match to the EBS1 5'-exon-binding site than the authentic IBS1 sequence in the 5' exon; (ii) exon ligation is unusually inefficient, and especially so when the 5' exon is truncated close to the second (IBS2) intron-binding site. We propose that reactions at the IBS1* site play a part in the regulation of the intron ISRm2011-2 host in vivo. | lld:pubmed |
pubmed-article:16460862 | pubmed:language | eng | lld:pubmed |
pubmed-article:16460862 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16460862 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16460862 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16460862 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16460862 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16460862 | pubmed:month | Jun | lld:pubmed |
pubmed-article:16460862 | pubmed:issn | 0300-9084 | lld:pubmed |
pubmed-article:16460862 | pubmed:author | pubmed-author:ToroNicolásN | lld:pubmed |
pubmed-article:16460862 | pubmed:author | pubmed-author:MichelFrançoi... | lld:pubmed |
pubmed-article:16460862 | pubmed:author | pubmed-author:CostaMaríaM | lld:pubmed |
pubmed-article:16460862 | pubmed:author | pubmed-author:Molina-Sánche... | lld:pubmed |
pubmed-article:16460862 | pubmed:author | pubmed-author:Martinez-Abar... | lld:pubmed |
pubmed-article:16460862 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16460862 | pubmed:volume | 88 | lld:pubmed |
pubmed-article:16460862 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16460862 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16460862 | pubmed:pagination | 711-7 | lld:pubmed |
pubmed-article:16460862 | pubmed:meshHeading | pubmed-meshheading:16460862... | lld:pubmed |
pubmed-article:16460862 | pubmed:meshHeading | pubmed-meshheading:16460862... | lld:pubmed |
pubmed-article:16460862 | pubmed:meshHeading | pubmed-meshheading:16460862... | lld:pubmed |
pubmed-article:16460862 | pubmed:meshHeading | pubmed-meshheading:16460862... | lld:pubmed |
pubmed-article:16460862 | pubmed:meshHeading | pubmed-meshheading:16460862... | lld:pubmed |
pubmed-article:16460862 | pubmed:meshHeading | pubmed-meshheading:16460862... | lld:pubmed |
pubmed-article:16460862 | pubmed:meshHeading | pubmed-meshheading:16460862... | lld:pubmed |
pubmed-article:16460862 | pubmed:meshHeading | pubmed-meshheading:16460862... | lld:pubmed |
pubmed-article:16460862 | pubmed:meshHeading | pubmed-meshheading:16460862... | lld:pubmed |
pubmed-article:16460862 | pubmed:meshHeading | pubmed-meshheading:16460862... | lld:pubmed |
pubmed-article:16460862 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16460862 | pubmed:articleTitle | An alternative intron-exon pairing scheme implied by unexpected in vitro activities of group II intron RmInt1 from Sinorhizobium meliloti. | lld:pubmed |
pubmed-article:16460862 | pubmed:affiliation | Centre de Genétique Moléculaire du CNRS, Avenue de la Terrasse, 91190 Gif-sur-Yvette, France. | lld:pubmed |
pubmed-article:16460862 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16460862 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16460862 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16460862 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16460862 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16460862 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16460862 | lld:pubmed |